Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 574
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06801236 Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-R… |
ACE-232 tablets | Cancer | Phase 1 | RECRUITING | En attente / non publié | Acerand Therapeutics (Hong Kong) … | United States, China · Beijing Gobroard Hospital, Bei… | 2025-05-12 → 2028-12-31 | Ouvrir |
| NCT07670312 Evaluation of XYA02 in Patients With Advanced Solid Tumors |
XYA02 | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | XYone Therapeutics, Inc | Australia · Chris O'Brien Life House, Sydney, Austral… | 2026-09-17 → 2030-09-15 | Ouvrir |
| NCT07164443 KLK2-comPAS — A Study of Pasritamig With or Without JNJ-87189401 Versus… |
Pasritamig | Cancer | Phase 3 | RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Australia, Belgium, Brazil, Canada, Ch… | 2025-09-02 → 2028-08-18 | Ouvrir |
| NCT06349408 IBI3001 in Participants With Unresectable, Locally Advanced or Metastat… |
IBI3001 | Cancer | Phase 1 | RECRUITING | En attente / non publié | Fortvita Biologics (USA)Inc. | United States, Australia, China · Anyang Cancer Hospi… | 2025-01-10 → 2027-12-31 | Ouvrir |
| NCT06091865 OLYMPIA-3 — A Study to Compare How Well Odronextamab Combined With Chem… |
Odronextamab | Cancer | Phase 3 | RECRUITING | En attente / non publié | Regeneron Pharmaceuticals | United States, Australia, Austria, Belgium, Brazil, C… | 2023-12-13 → 2029-09-12 | Ouvrir |
| NCT07841002 CLL-1-Targeted In Vivo CAR-T Cell Immunotherapy for Relapsed/Refractory… |
SL1CC Injection | Cancer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Liping Dou | China · Chinese PLA General Hospital, Beijing, Beijin… | 2026-09-30 → 2030-09-30 | Ouvrir |
| NCT07377006 Decision Support Tool to Enhance Germline Genetic Testing for Patients … |
Biospecimen Collection | Cancer | Non applicable | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · M D Anderson Cancer Center, Houston, … | 2026-02-02 → 2030-12-31 | Ouvrir |
| NCT07704970 QLESP Block for Pain Control in Robotic Partial Nephrectomy |
ropivacaine (local infiltration) | Cancer | Non applicable | RECRUITING | En attente / non publié | Huazhong University of Science an… | China · Union Hospital, Tongji Medical College, Huazh… | 2026-09-22 → 2027-03-31 | Ouvrir |
| NCT04606381 PALOMA — A Study of Amivantamab Subcutaneous (SC) Administration for th… |
Ami-LC-MD | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Canada, South Korea, United Kingdom · … | 2020-11-10 → 2027-04-01 | Ouvrir |
| NCT05132075 KontRASt-02 — Study of JDQ443 in Comparison With Docetaxel in Participa… |
JDQ443 | Cancer | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Canada, China, F… | 2022-06-15 → 2026-10-03 | Ouvrir |
| NCT07842835 Registry of an Integrated Longitudinal Multimodal Biospecimen Biobank f… |
High-dose methotrexate-based ther… | Cancer | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Xiaohui Ren | China · Deparment of neurosurgery, Beijing tiantan ho… | 2026-10-01 → 2031-07-31 | Ouvrir |
| NCT06667908 CONVERGE — A Study of JNJ-90301900 in Combination With Chemoradiation F… |
JNJ-90301900 | Cancer | Phase 2 | RECRUITING | En attente / non publié | Johnson & Johnson Enterprise Inno… | United States, Australia, Brazil, China, France, Hong… | 2024-12-06 → 2028-12-31 | Ouvrir |
| NCT07524530 Stem Cell Transplantation for Participants With Germline RUNX1 Associat… |
Cyclophosphamide | Cancer | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Hebei Senlang Biotechnology Inc.,… | United States · National Institutes of Health Clinica… | 2026-09-30 → 2036-06-01 | Ouvrir |
| NCT05152147 HERIZON-GEA-01 — A Study of Zanidatamab in Combination With Chemotherap… |
Zanidatamab | Parkinson | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Jazz Pharmaceuticals | Argentina, Australia, Belgium, Brazil, Canada, Chile,… | 2021-12-02 → 2027-09-30 | Ouvrir |
| NCT00244985 Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed … |
Rituximab | SEP | Phase 1/2 | COMPLETED | En attente / non publié | M.D. Anderson Cancer Center | United States · Roswell Park Cancer Institute, Buffal… | 2005-09 → 2012-12 | Ouvrir |
| NCT00244855 Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hod… |
Rituximab | SEP | Phase 2 | COMPLETED | En attente / non publié | M.D. Anderson Cancer Center | United States · Fred Hutchinson Cancer Research Cente… | 2004-05 → 2011-08-29 | Ouvrir |
| NCT02143414 Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and… |
Biopsy Procedure | SEP | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Ascension Via Christi Hospitals Wichi… | 2015-06-30 → 2027-06-06 | Ouvrir |
| NCT06248086 A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive… |
ASP2802 | SEP | Phase 1 | TERMINATED | En attente / non publié | Astellas Pharma Global Developmen… | Australia · Site AU61004, Sydney, Australia | 2024-09-06 → 2024-12-01 | Ouvrir |
| NCT00006669 Rituximab Followed by Combination Chemotherapy in Treating Patients Wit… |
Rituximab | SEP | Phase 2 | WITHDRAWN | En attente / non publié | M.D. Anderson Cancer Center | United States · Franklin Square Hospital Center, Balt… | 1999-09 → 2000-01 | Ouvrir |
| NCT07444281 An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With… |
C-CAR031 | SEP | Phase 1 | RECRUITING | En attente / non publié | Shanghai AbelZeta Ltd. | China · Shanghai Chest hospital, Shanghai, China | 2024-12-25 → 2028-01-30 | Ouvrir |
| NCT01423006 Pilot Study on Focal Prostate Radio-Frequency Ablation |
Radio-Frequency Ablation (RFA) EN… | Cancer | Non applicable | COMPLETED | En attente / non publié | H. Lee Moffitt Cancer Center and … | United States · H. Lee Moffitt Cancer Center and Rese… | 2011-08 → 2013-03 | Ouvrir |
| NCT05350059 The HIFUB Study (HIFU in Breast Cancer) |
High Intensity Focused Ultrasound… | Cancer | Non applicable | UNKNOWN | En attente / non publié | University of Oxford | Non communiqué | 2022-05-01 → 2022-11-01 | Ouvrir |
| NCT03927924 High-intensity Focused Ultrasound Study |
High-intensity focused ultrasound | Cancer | Non applicable | TERMINATED | En attente / non publié | Chinese University of Hong Kong | Hong Kong · The Chinese University of Hong Kong, Hong… | 2019-06-25 → 2021-01-28 | Ouvrir |
| NCT02629978 Radiofrequency Ablation of Malignant Pulmonary Nodules |
CT-guided percutaneous radiofrequ… | Cancer | Non applicable | UNKNOWN | En attente / non publié | Chinese PLA General Hospital | China · The Chinese PLA General Hospital, Beijing, Ch… | 2015-10 → 2020-10 | Ouvrir |
| NCT03614910 Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreve… |
Nanoknife Irreversible Electropor… | Cancer | À vérifier | COMPLETED | En attente / non publié | Holy Name Medical Center, Inc. | United States · Holy Name Medical Center, Teaneck, Un… | 2018-05-15 → 2021-05-01 | Ouvrir |